Journal profile · Engineering-Biomedical Engineering
npj Regenerative Medicine
ISSN 2057-3995 · Springer Nature · ENGLAND · Founded 2016
npj Regenerative Medicine: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 6.95; fully open access; APC about USD 4,390; median 217 days to acceptance (98 articles, last 24 months); 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
npj Regenerative Medicine is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Tissue Engineering and Regenerative Medicine, Mesenchymal stem cell research and Pluripotent Stem Cells Research, together about 32.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
npj Regenerative Medicine is an open access, online-only journal dedicated to publishing the highest quality research into ways to help the human body repair, replace, restore and regenerate damaged tissues and organs.
From the journal's Aims & Scope
Research area (LetPub): Engineering-Biomedical Engineering
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tissue Engineering and Regenerative MedicineMedicine15.3%
- Mesenchymal stem cell researchMedicine9.5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology7.6%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science5.5%
- Wound Healing and TreatmentsMedicine5.5%
- Muscle Physiology and DisordersBiochemistry, Genetics and Molecular Biology5.3%
- Congenital heart defects researchBiochemistry, Genetics and Molecular Biology4.9%
- Nerve injury and regenerationNeuroscience4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell & Tissue Engineering | Zone 2 |
| Minor | Engineering, Biomedical | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Cell & Tissue Engineering | Zone 1 |
| Minor | Engineering, Biomedical | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Engineering, Biomedical | Zone 1 |
| Minor | Cell & Tissue Engineering | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexWeb of ScienceEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Astrophysics Data System, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.95LetPub ·
- Impact factor (publisher) 2025
- 7Publisher website ·
- 5-year impact factor (publisher) 2025
- 8.1Publisher website ·
- CiteScore 2026-06
- 11.8LetPub ·
- SJR 2026-06
- 1.92LetPub ·
- SNIP 2026-06
- 1.55LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 347OpenAlex ·
- 2-year mean citedness
- 6.12OpenAlex ·
- Self-citation rate
- 1.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 61LetPub ·
- Downloads per year (publisher) 2025
- 1,449,397Publisher website ·
Articles by year OpenAlex count · 513 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 58 | 23 |
| 2025 | 61 | 61 | 426 |
| 2024 | 43 | 43 | 542 |
| 2023 | 68 | 68 | 1,501 |
| 2022 | 78 | 78 | 2,347 |
| 2021 | 85 | 85 | 3,953 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
217 daysMedian, submission to acceptance · P25–P75 165 days – 273 days
- Acceptance to online
- median 18 days (98 articles)
- Submission to online
- median 235 days
- Sample
- 98 articles with submission and acceptance dates (138 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,590 / USD 4,390 / GBP 3,190 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 4,190 / EUR 3,490 / GBP 3,090 | — | — | |
| LetPub | GBP 2,890 / USD 3,890 / EUR 3,290 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
npj Regenerative Medicine is a fully open access journal. More on Creative Commons Attribution licenses and the benefits of publishing open access can be found in this section.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2016
- ISSN
- 2057-3995
- Society / sponsor
- Published in partnership with
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about npj Regenerative Medicine
What CAS zone is npj Regenerative Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, npj Regenerative Medicine is in Zone 1 of Medicine, and in Zone 2 of the minor category Cell & Tissue Engineering / Engineering, Biomedical; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of npj Regenerative Medicine?
The latest impact factor listed by LetPub is 6.95; CiteScore 11.8, h-index 67.
How long does peer review take at npj Regenerative Medicine?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 217 days (interquartile range 165–273 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index npj Regenerative Medicine?
According to LetPub and DOAJ records, npj Regenerative Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists EI Compendex, Web of Science, Embase and CAS; that list has not been checked against each database.
Is npj Regenerative Medicine open access, and what is the APC?
npj Regenerative Medicine is a fully open-access journal. APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .